These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23512269)

  • 1. Physical and chemical stability of high-dose ifosfamide and mesna for prolonged 14-day continuous infusion.
    Zhang Y; Kawedia JD; Myers AL; McIntyre CM; Anderson PM; Kramer MA; Culotta KS
    J Oncol Pharm Pract; 2014 Feb; 20(1):51-7. PubMed ID: 23512269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The stability of ifosfamide in aqueous solution and its suitability for continuous 7-day infusion by ambulatory pump.
    Radford JA; Margison JM; Swindell R; Lind MJ; Wilkinson PM; Thatcher N
    J Cancer Res Clin Oncol; 1991; 117 Suppl 4():S154-6. PubMed ID: 1795005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of cyclophosphamide and mesna admixtures in polyethylene infusion bags.
    Menard C; Bourguignon C; Schlatter J; Vermerie N
    Ann Pharmacother; 2003 Dec; 37(12):1789-92. PubMed ID: 14632591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of ifosfamide in solutions for multiday infusion by external pump.
    Leone L; Comandone A; Oliva C; Bussi P; Goffredo F; Bretti S; Bumma C
    Anticancer Drugs; 1995 Aug; 6(4):604-7. PubMed ID: 7579566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term stability study of clofarabine injection concentrate and diluted clofarabine infusion solutions.
    Kaiser J; Krämer I
    J Oncol Pharm Pract; 2012 Jun; 18(2):213-21. PubMed ID: 22075005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the stability profile of anticancer drugs: A review of Ifosfamide and Mesna regimen for the treatment of metastatic soft tissue sarcoma.
    Salman D; Swinden J; Barton S; Peron JM; Nabhani-Gebara S
    J Oncol Pharm Pract; 2016 Feb; 22(1):86-91. PubMed ID: 25178698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical and chemical stability of reconstituted and diluted dexrazoxane infusion solutions.
    Zhang YP; Myers AL; Trinh VA; Kawedia JD; Kramer MA; Benjamin RS; Tran HT
    J Oncol Pharm Pract; 2014 Feb; 20(1):58-64. PubMed ID: 23676513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambulatory administration of 5-day infusion ifosfamide+mesna: a pilot study in sarcoma patients.
    Coriat R; Mir O; Camps S; Ropert S; Billemont B; Leconte M; Larousserie F; Anract P; Alexandre J; Goldwasser F
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):491-5. PubMed ID: 19588140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability study of carboplatin infusion solutions in 0.9% sodium chloride in polyvinyl chloride bags.
    Myers AL; Zhang YP; Kawedia JD; Trinh VA; Tran H; Smith JA; Kramer MA
    J Oncol Pharm Pract; 2016 Feb; 22(1):31-6. PubMed ID: 25122633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I study of prolonged ambulatory infusion of Ifosfamide with oral mesna.
    Olver I; Keefe D; Myers M; Caruso D
    Chemotherapy; 2005 May; 51(2-3):142-6. PubMed ID: 15886474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory high-dose 5-day continuous-infusion ifosfamide combination chemotherapy in advanced solid tumors: a feasibility study.
    Loeffler TM; Weber FW; Hausamen TU
    J Cancer Res Clin Oncol; 1991; 117 Suppl 4():S125-8. PubMed ID: 1795000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infusion of ifosfamide plus mesna.
    Rowland CG; Bradford E; Adams P; Haines-Nutt RP; Jakobson K
    Lancet; 1984 Aug; 2(8400):468. PubMed ID: 6147537
    [No Abstract]   [Full Text] [Related]  

  • 13. The stability of ifosfamide in aqueous solution and its suitability for continuous 7-day infusion by ambulatory pump.
    Radford JA; Margison JM; Swindell R; Lind MJ; Wilkinson PM; Thatcher N
    Cancer Chemother Pharmacol; 1990; 26(2):144-6. PubMed ID: 2347040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined intravenous and oral mesna in outpatients treated with ifosfamide.
    Goren MP; McKenna LM; Goodman TL
    Cancer Chemother Pharmacol; 1997; 40(5):371-5. PubMed ID: 9272112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of ifosfamide in 0.9% sodium chloride solution or water for injection in a portable i.v. pump cassette.
    Muñoz M; Girona V; Pujol M; Durán S; Vicente P; Solé LA
    Am J Hosp Pharm; 1992 May; 49(5):1137-9. PubMed ID: 1595743
    [No Abstract]   [Full Text] [Related]  

  • 17. Full-dose ifosfamide can be safely administered to outpatients.
    Meazza C; Bisogno G; Casanova M; Zanetti I; Carli M; Ferrari A
    Pediatr Blood Cancer; 2008 Feb; 50(2):375-8. PubMed ID: 16847930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ifosfamide continuous infusion without mesna. A phase I trial of a 14-day cycle.
    Lokich I; Anderson N; Bern M; Moore C
    Cancer; 1991 Feb; 67(4):883-5. PubMed ID: 1899352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of a 24-h continuous infusion of ifosfamide/mesna in acute lymphoblastic leukemia.
    Otero JC; Solidoro A; Casanova L; Vallejos C; Rodriguez W
    J Exp Ther Oncol; 1996 Mar; 1(2):84-7. PubMed ID: 9414391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ifosfamide and mesna: response and toxicity at standard- and high-dose schedules.
    Antman KH; Elias A; Ryan L
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):68-73. PubMed ID: 2110386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.